Ms Amanda Kosinski
Tel: +44 (0)20 7905 2119
Fees and funding
Full details of funding opportunities can be found on the UCL Scholarships website
Research Assessment Rating
70% rated 4* (world-leading) or 3* (internationally excellent)
(What is the RAE?)
The programme information on this page relates to 2013 entry. 2014 content to appear here shortly.
Cell and Gene Therapy MSc
This Master's degree in Cell and Gene Therapy provides an in-depth education in this cutting edge and rapidly developing field. It is delivered by scientists and clinicians researching, developing and testing new treatments for genetically inherited and acquired diseases using gene delivery technology, stem cell manipulation and DNA repair techniques.
What will I learn?
The degree covers all aspects of the subject, including basic biomedical science, molecular basis of disease, current and developing technologies and clinical applications. Students also receive vocational training in research methodology and statistics, how to perform a research project and in completing a practical laboratory based project.
Why should I study this degree at UCL?
The Institute of Child Health (ICH), and its clinical partner Great Ormond Street Hospital (GOSH), is the largest centre in Europe devoted to clinical and basic research and post-graduate education in children's health. ICH/GOSH is a major centre for cell therapy, including haematopoietic stem cell transplantation (HSCT) and gene therapy.
This centre has treated more patients in clinical trials of gene therapy than any other institution worldwide, currently conducting three clinical trials of gene therapy for three separate disorders, with clinical trials for additional disorders, including some forms of cancer, in development.
There is a strong research interest in cell and gene therapy within the Faculty of Biomedical Sciences at UCL, which has the largest concentration of clinicians and researchers active in this area of translational medicine in Europe. This is reflected by many groups conducting high-quality research and clinical trials using gene or cell therapy, including Infection and Immunity, Institute of Ophthalmology, Institute for Women's Health, Institute of Genetics and the Cancer Institute.
See subject website for more information:
Availability: Full-time 1 year (flexible 2-5 years)
Students undertake modules to the value of 180 credits. The MSc programme consists of four core modules (60 credits), four optional modules (60 credits) and a research dissertation (60 credits).
A Postgraduate Diploma (120 credits, full-time nine months or part-time up to five years) is offered
A Postgraduate Certificate (60 credits, full-time 12 weeks or up to two years part-time) is offered.
All MSc students undertake an independent research project which culminates in a dissertation.
Teaching and Learning
Teaching includes lectures, seminars, problem classes and tutorials. Course assessment varies depending on the course, but includes written coursework, multiple-choice questions, written examinations, a practical analysis exam and the dissertation.
Further details available on subject website:
Entry and application
Applicants should be: a qualified medical practitioner, with a qualification equivalent to a UK MB BS, a non-clinical scientist with a minimum of an upper second-class BSc or equivalent in a life or biomedical science subject; or a healthcare, pharmaceutical or biotech professional and scientist with equivalent experience (minimum 3 years).
For overseas equivalencies see the relevant country page.
How to apply
You may choose to apply online or download application materials; for details visit www.ucl.ac.uk/gradapps
The deadline for applications is 2 August 2013. Students are advised to apply as early as possible. Those applying for scholarship funding (particularly overseas applicants) should take note of application deadlines.
Who can apply?
The programme is designed for medics and scientists who would like to develop their knowledge in this distinct area, with a view to contributing to research and clinical trials in the field.
What are we looking for?
When we assess your application we would like to learn:
- why you want to study Cell and Gene Therapy at graduate level
- why you want to study Cell and Gene Therapy at UCL
- what particularly attracts you to this programme
- how your academic and professional background meets the demands of this challenging programme
- where you would like to go professionally with your degree
The first cohort of students admitted to the Cell and Gene Therapy MSc programme are due to graduate in 2012. Therefore, no information about career destinations for students on this programme is currently available.
Find out more about London graduates' careers by visiting the Careers Group (University of London) website: